global-blood-glucose-monitoring-market-industry
Published

MAY 2018

Blood Glucose Monitoring Market Size, Share - Segmented by Type of Device (Blood Glucose Meter, Blood Glucose Testing Strips, Lancets, Continuous Glucose Monitoring Devices), Geography - Growth, Trends, and Forecast (2018 — 2023)

Purchase Report
$5000
Single user license
$5250
Team license
$9500
Corporate license

Blood Glucose Monitoring Market 

The Blood Glucose Monitoring Market is expected to register a CAGR of  5.6% during the forecast period of 2018–2023. Blood glucose monitoring devices are used for effective diabetes diagnosis and treatment.

Global Rise in Diabetic population

Diabetes is a chronic disorder, which occurs when the pancreas is unable to produce insulin required for the body or when the body fails to use the insulin which is produced by the pancreas.  Diabetes is caused by several factors, such as sedentary lifestyle, obesity, unhealthy diets, pollution, and others. The incidence and prevalence of diabetes is increasing rapidly. Once diabetes is diagnosed, it is a life time treatment. According to WHO statistics, the prevalence of diabetes in the African region has increased from 3.1% in 1980 to 7.1% in 2014. In North America, the prevalence of diabetes has increased from 5% in 1980 to 8.3% in 2014. In Europe, the prevalence of diabetes has increased from 5.3% in 1980 to 7.3% in 2014. In Asia-Pacific, the prevalence of diabetes has increased from 4.1% in 1980 to 8.6% in 2014. It is evident from WHO’s diabetes statistics that the diabetic population is increasing rapidly. There is a huge requirement of glucose monitoring devices for diagnosis and treatment of diabetes. Hence, a rise in the diabetic population drives the market by increasing the use of blood glucose monitoring devices. The other factors, such as technological innovations, the convenience of Conventional Glucose Monitoring over conventional monitoring, early detection of hypo and hyperglycaemic diabetes are the major drivers for the market.

Less Attractive Reimbursement Coverage

Laboratories are a crucial part of glucose monitoring. Planned cuts in reimbursement rates are being made to the Centre for Medicare & Medicaid Services (CMS) that are responsible for healthcare insurance programs. Under the last law of Protecting Access to Medicare Act, 2014 (PAMA), the applicable labs must report their test volumes and private payer rates to CMS. As a result, the labs will receive less revenue for the same volume of tests. This applies to tests that exist now and has already obtained Medicare coverage.

The cuts in reimbursement rates have led to uncertainties in lab investments, which is a major restraining factor for the growth of glucose monitoring devices market. The other factors such as reimbursement issues and patent expiry depleted profit of market are the major restraints for the blood glucose monitoring market.

Asia Pacific Leads the Blood Glucose Monitoring Market 

In 2017, Asia Pacific held the largest share in the blood glucose monitoring market due to the large patient pool and wide acceptance of advanced technologies.

                                              

Key Developments in the Blood Glucose Monitoring Market 

  • March 2018: Medtronic received FDA approval for new smart continuous glucose monitor for diabetes.
  • Sep 2017: Abbott received FDA approval for first continuous glucose monitoring system for adults not requiring blood sample calibration.

Blood Glucose Monitoring Market Major Players : Abbott Laboratories, Arkay Inc , B. Braun Melsungen AG, Bayer Healthcare AG, Becton Dickinson, F. Hoffmann-La Roche, LifeScan, Medtronic, Novel Biomedical Corporation, Terumo Europe N.V.

Reasons to Purchase Blood Glucose Monitoring Market Report

  • Follow the current and future global blood glucose monitoring market in the developed and emerging markets.
  • Examining the various perspectives of the market with the help of Porter’s Five Forces Analysis.
  • Identify the segment that is expected to dominate the market.
  • Identify the regions that are expected to witness the fastest growth during the forecast period.
  • Identify the latest developments, market shares, and strategies employed by the major market players.
  • 3 month analyst support along with the Market Estimate sheet (in Excel).

Customize Blood Glucose Monitoring Market  Report

  • This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Diabetes Devices Intelligence Center

Covering 3 categories, 8 segments across 25 countries - offering over 8,600 data points

Our Clients Include View All

Looking to Customize Report?